John Rothman
Impact in
- Biotechnology top 5%
- Cancer Research and Treatments
- Listeria monocytogenes in Food Safety
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
-
- Cancer Research and Treatments 7
- Listeria monocytogenes in Food Safety 3
-
- Immunotherapy and Immune Responses 5
- Co-authors
- Siniša Radulović (2 shared papers)Paulo Maciag (2 shared papers)Reshma Singh (3 shared papers)Anu Wallecha (4 shared papers)Yvonne Paterson (1 shared paper)Konstantin Golovine (1 shared paper)Vladimir Kolenko (1 shared paper)Rasha Abu Eid (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Expert Review of Vaccines (1 paper)Annals of the New York Academy of Sciences (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- United StatesMalaysiaSerbia
In The Last Decade
John Rothman
13 papers receiving 559 citations
Peers
Comparison fields: 5 of 64
- Biotechnology 180
- Immunology 231
- Oncology 165
- Epidemiology 116
- Genetics 82
Countries citing papers authored by John Rothman
This map shows the geographic impact of John Rothman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Rothman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Rothman more than expected).
Fields of papers citing papers by John Rothman
This network shows the impact of papers produced by John Rothman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Rothman. The network helps show where John Rothman may publish in the future.
Co-authors
The 25 scholars most cited alongside John Rothman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 262 | |
| 2 | 2008 | 62 | |
| 3 | 2013 | 56 | |
| 4 | 2012 | 42 | |
| 5 | 2013 | 36 | |
| 6 | 2012 | 32 | |
| 7 | 1984 | 30 | |
| 8 | 1984 | 24 | |
| 9 | Therapeutic cancer vaccines in cervical cancer: phase I study of Lovaxin-C. | 2009 | 23 |
| 10 | Does month of birth affect risk of Crohn's disease in childhood and adolescence? | 2001 | 2 |
| 11 | 2010 | 2 | |
| 12 | 2008 | 1 | |
| 13 | 2012 | 1 |
About John Rothman
John Rothman is a scholar working on Biotechnology, Immunology, Epidemiology, Biomedical Engineering and Oncology, having authored 13 papers that have together received 573 indexed citations. Recurring topics across this work include Cancer Research and Treatments (7 papers), Immunotherapy and Immune Responses (5 papers), Listeria monocytogenes in Food Safety (3 papers), Nanoplatforms for cancer theranostics (3 papers), Hepatitis B Virus Studies (2 papers), Cervical Cancer and HPV Research (2 papers), Surgical site infection prevention (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Biotechnology (180 citations), Immunology (231 citations), Oncology (165 citations), Epidemiology (116 citations) and Genetics (82 citations). John Rothman has collaborated with scholars based in United States, Malaysia and Serbia. Frequent co-authors include Siniša Radulović, Paulo Maciag, Reshma Singh, Anu Wallecha, Yvonne Paterson, Konstantin Golovine, Vladimir Kolenko, Rasha Abu Eid, Benjamin Scoll and Peter Makhov. Their work appears in journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Expert Review of Vaccines, Annals of the New York Academy of Sciences and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.